Nonagen Therapeutics
Pre-clinicalNonagen Therapeutics Discovering and Developing Breakthrough Therapeutics for Human Cancers
Founded
2018
Focus
NeuroscienceRegenerative Medicine
About
Nonagen Therapeutics Discovering and Developing Breakthrough Therapeutics for Human Cancers
Funding History
2Total raised: $17.5M
Series A$15MUndisclosedOct 15, 2022
Seed$2.5MUndisclosedJun 15, 2021
Company Info
TypePrivate
Founded2018
LocationCambridge, United Kingdom
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile